NUS Financial Facts

Selling expenses: 234.01M
Total operating expenses: 369.63M
See Full Income Statement

Accumulated other comprehensive loss: -61.98M
Accrued expenses: 292.3M
See Full Balance Sheet

Nu Skin Enterprises Inc. (NUS) Earnings

  |   Expand Research on NUS
Next EPS Date 8/6/15 *Est. EPS Growth Rate -31.4% *Last Qtr.
Average EPS % Beat Rate +3.6% Revenue Growth Rate -19.0% *Last Qtr.
Average % Move 1-Wk after EPS -6.0% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/6/15 Q115 $0.72$0.73 -$0.01$543.3M$544.7M = Details
2/5/15 Q414 $0.85$0.80 +$0.05$609.6M$600.2M = Details
11/5/14 Q314 $1.12$0.93 +$0.19$638.8M$628.83M = Details
8/6/14 Q214 $1.13$1.27 -$0.14$650M$709.03M Details
5/6/14 Q114 $1.05$0.94 +$0.11$671.1M$656.82M = Details
3/3/14 Q413 $2.02$1.99 +$0.03$1.06B$1.07B = Details
10/22/13 Q313 $1.80$1.41 +$0.39$927M$806.19M Details
8/1/13 Q213 $1.22$0.96 +$0.26$682.9M$579.1M Details